160 related articles for article (PubMed ID: 24878981)
21. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
[TBL] [Abstract][Full Text] [Related]
23. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
[TBL] [Abstract][Full Text] [Related]
24. Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial.
Schiel R; Müller UA; Beltschikow W; Stein G
J Diabetes Complications; 2006; 20(5):273-9. PubMed ID: 16949513
[TBL] [Abstract][Full Text] [Related]
25. Caribbean female patients with type 2 diabetes mellitus have lower serum levels of adiponectin than nondiabetic subjects.
Ezenwaka CE; Kalloo R
Neth J Med; 2005 Feb; 63(2):64-9. PubMed ID: 15766010
[TBL] [Abstract][Full Text] [Related]
26. [Metabolic disorders in renal transplant recipients].
Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
[TBL] [Abstract][Full Text] [Related]
27. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM; Candrilli SD; Kanyongo G
Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM
Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
[TBL] [Abstract][Full Text] [Related]
29. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
[No Abstract] [Full Text] [Related]
30. Metalloproteinase Inhibition Protects against Reductions in Circulating Adrenomedullin during Lead-induced Acute Hypertension.
Nascimento RA; Mendes G; Possomato-Vieira JS; Gonçalves-Rizzi VH; Kushima H; Delella FK; Dias-Junior CA
Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):508-15. PubMed ID: 25308714
[TBL] [Abstract][Full Text] [Related]
31. The effect of high-fat diet and streptozotocin-induced diabetes and endurance training on plasma levels of calcitonin gene-related peptide and lactate in rats.
Daneshyar S; Gharakhanlou R; Nikooie R; Forutan Y
Can J Diabetes; 2014 Dec; 38(6):461-5. PubMed ID: 25219961
[TBL] [Abstract][Full Text] [Related]
32. Plasma adrenomedullin and subclinical cardiorenal syndrome in patients with type 2 diabetes mellitus.
Pecková M; Charvat J; Schuck O; Zamrazil V; Bilek R; Hill M; Svab P; Horackova M
J Int Med Res; 2012; 40(4):1552-9. PubMed ID: 22971508
[TBL] [Abstract][Full Text] [Related]
33. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
Nadal JF; Gutiérrez PC
Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
[TBL] [Abstract][Full Text] [Related]
34. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
Briskman I; Bar G; Boaz M; Shargorodsky M
Int J Psychiatry Med; 2012; 43(4):339-48. PubMed ID: 23094466
[TBL] [Abstract][Full Text] [Related]
35. Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.
Kimando MW; Otieno FCF; Ogola EN; Mutai K
BMC Endocr Disord; 2017 Dec; 17(1):73. PubMed ID: 29191193
[TBL] [Abstract][Full Text] [Related]
36. Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.
Sakamoto M; Edo N; Takahashi S; Okamura E; Uno K; Morita K; Ishikawa T; Asahi K; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kimura K; Ohashi Y; Watanabe T; Tsukamoto K
J Atheroscler Thromb; 2019 Sep; 26(9):805-820. PubMed ID: 30726791
[TBL] [Abstract][Full Text] [Related]
37. [Study on the level of plasma calcitonin gene-related peptide and adrenomedullin in subjects with primary osteoporosis].
Lin J; Lü C; Gao L
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):841-3. PubMed ID: 11702676
[TBL] [Abstract][Full Text] [Related]
38. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia.
Mengual L; Roura P; Serra M; Montasell M; Prieto G; Bonet S
Cardiovasc Diabetol; 2010 Mar; 9():14. PubMed ID: 20350315
[TBL] [Abstract][Full Text] [Related]
39. Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation.
Rückert IM; Maier W; Mielck A; Schipf S; Völzke H; Kluttig A; Greiser KH; Berger K; Müller G; Ellert U; Neuhauser H; Rathmann W; Tamayo T; Moebus S; Andrich S; Meisinger C
Cardiovasc Diabetol; 2012 Oct; 11():120. PubMed ID: 23035799
[TBL] [Abstract][Full Text] [Related]
40. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
Robins SJ
Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
